Jeffrey S. Osborn

3.1k total citations
50 papers, 2.0k citations indexed

About

Jeffrey S. Osborn is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Jeffrey S. Osborn has authored 50 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Cardiology and Cardiovascular Medicine, 4 papers in Radiology, Nuclear Medicine and Imaging and 3 papers in Surgery. Recurrent topics in Jeffrey S. Osborn's work include Atrial Fibrillation Management and Outcomes (35 papers), Cardiac Arrhythmias and Treatments (25 papers) and Cardiac pacing and defibrillation studies (16 papers). Jeffrey S. Osborn is often cited by papers focused on Atrial Fibrillation Management and Outcomes (35 papers), Cardiac Arrhythmias and Treatments (25 papers) and Cardiac pacing and defibrillation studies (16 papers). Jeffrey S. Osborn collaborates with scholars based in United States, Australia and Hong Kong. Jeffrey S. Osborn's co-authors include T. Jared Bunch, Brian G. Crandall, J. Peter Weiss, John Day, Heidi T. May, Tami L. Bair, Jeffrey L. Anderson, Donald Lappé, Charles Mallender and Joseph B. Muhlestein and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Jeffrey S. Osborn

50 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey S. Osborn United States	24	1.8k	359	145	138	136	50	2.0k
J. Peter Weiss United States	28	2.0k 1.1×	398 1.1×	161 1.1×	136 1.0×	201 1.5×	72	2.3k
Brian G. Crandall United States	28	2.0k 1.1×	415 1.2×	165 1.1×	127 0.9×	243 1.8×	58	2.4k
Eunsun Jang South Korea	26	1.8k 1.0×	354 1.0×	66 0.5×	134 1.0×	106 0.8×	82	2.1k
Tze‐Fan Chao Taiwan	29	1.9k 1.1×	332 0.9×	175 1.2×	222 1.6×	165 1.2×	75	2.3k
Alena Shantsila United Kingdom	25	1.4k 0.8×	171 0.5×	174 1.2×	149 1.1×	172 1.3×	94	1.8k
Ribo Tang China	22	1.6k 0.9×	107 0.3×	95 0.7×	96 0.7×	159 1.2×	150	1.8k
D. Twomey Australia	18	3.0k 1.7×	174 0.5×	121 0.8×	270 2.0×	355 2.6×	36	3.2k
Thierry Danays France	15	659 0.4×	318 0.9×	141 1.0×	168 1.2×	292 2.1×	37	1.1k
Jakob Raunsø Denmark	14	1.1k 0.6×	187 0.5×	91 0.6×	63 0.5×	176 1.3×	19	1.4k
Syed M. Jafri United States	18	1.5k 0.8×	195 0.5×	156 1.1×	135 1.0×	315 2.3×	53	1.8k

Countries citing papers authored by Jeffrey S. Osborn

Since Specialization

Citations

This map shows the geographic impact of Jeffrey S. Osborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey S. Osborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey S. Osborn more than expected).

Fields of papers citing papers by Jeffrey S. Osborn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey S. Osborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey S. Osborn. The network helps show where Jeffrey S. Osborn may publish in the future.

Co-authorship network of co-authors of Jeffrey S. Osborn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey S. Osborn. A scholar is included among the top collaborators of Jeffrey S. Osborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey S. Osborn. Jeffrey S. Osborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cutler, Michael J., Tami L. Bair, Brian G. Crandall, et al.. (2024). PO-04-055 CLINICAL, ECONOMIC AND HEALTHCARE UTILIZATION IMPACT OF EARLY AMBULATION USING PROGLIDE VENOUS CLOSURE FOLLOWING ATRIAL FIBRILLATION ABLATION. Heart Rhythm. 21(5). S476–S476. 1 indexed citations

Cutler, Michael J., Heidi T. May, Tami L. Bair, et al.. (2022). Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19. IJC Heart & Vasculature. 43. 101127–101127. 10 indexed citations

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2019). Long-term outcomes after low power, slower movement versus high power, faster movement irrigated-tip catheter ablation for atrial fibrillation. Heart Rhythm. 17(2). 184–189. 48 indexed citations

May, Heidi T., Tami L. Bair, Victoria Jacobs, et al.. (2018). The Impact of Gender on Atrial Fibrillation Incidence and Progression to Dementia. The American Journal of Cardiology. 122(9). 1489–1495. 7 indexed citations

Mason, Steve, Jeffrey S. Osborn, Ritesh Dhar, et al.. (2017). Real world MRI experience with nonconditional and conditional cardiac rhythm devices after MagnaSafe. Journal of Cardiovascular Electrophysiology. 28(12). 1468–1474. 14 indexed citations

May, Heidi T., Tami L. Bair, Victoria Jacobs, et al.. (2017). The Population-Based Long-Term Impact of Anticoagulant and Antiplatelet Therapies in Low-Risk Patients With Atrial Fibrillation. The American Journal of Cardiology. 120(1). 75–82. 4 indexed citations

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2016). Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation. The American Journal of Cardiology. 118(2). 210–214. 111 indexed citations

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2016). Long-term influence of body mass index on cardiovascular events after atrial fibrillation ablation. Journal of Interventional Cardiac Electrophysiology. 46(3). 259–265. 27 indexed citations

Hummel, John D., Jeffrey S. Osborn, Raymond Yee, et al.. (2016). Real‐World Assessment of Acute Left Ventricular Lead Implant Success and Complication Rates: Results from the Attain Success Clinical Trial. Pacing and Clinical Electrophysiology. 39(11). 1246–1253. 16 indexed citations

10.

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2015). Abstract 11938: Long-term Population-based Outcomes of Novel Oral Anticoagulants Compared to Warfarin Among Long-term Anticoagulated Patients: A Propensity Matched Analysis. Circulation. 132(suppl_3). 1 indexed citations

11.

Jacobs, Victoria, Scott C. Woller, Scott M. Stevens, et al.. (2015). Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia. Journal of Cardiovascular Electrophysiology. 26(11). 1180–1186. 32 indexed citations

12.

Sheldon, Seth H., T. Jared Bunch, Gregory Cogert, et al.. (2014). MULTICENTER STUDY OF THE SAFETY AND EFFECTS OF MAGNETIC RESONANCE IMAGING IN PATIENTS WITH CORONARY SINUS LEFT VENTRICULAR PACING LEADS. Journal of the American College of Cardiology. 63(12). A380–A380. 3 indexed citations

13.

Bunch, T. Jared, Heidi T. May, Tami L. Bair, et al.. (2014). Abstract 13426: Percent Time With a Supratherapeutic Inr in Atrial Fibrillation Patients Using an Antiplatelet Agent is Associated With Long-term Risk of Dementia. Circulation. 130(suppl_2). 1 indexed citations

14.

Sheldon, Seth H., T. Jared Bunch, Gregory Cogert, et al.. (2014). Multicenter study of the safety and effects of magnetic resonance imaging in patients with coronary sinus left ventricular pacing leads. Heart Rhythm. 12(2). 345–349. 20 indexed citations

15.

Jacobs, Victoria, Scott C. Woller, Scott M. Stevens, et al.. (2014). Time outside of therapeutic range in atrial fibrillation patients is associated with long-term risk of dementia. Heart Rhythm. 11(12). 2206–2213. 118 indexed citations

16.

Jacobs, Victoria, Heidi T. May, Tami L. Bair, et al.. (2014). The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation. Heart Rhythm. 12(4). 681–686. 72 indexed citations

17.

May, Heidi T., Jeffrey L. Anderson, Joseph B Muhlestein, et al.. (2011). Abstract 14699: Vitamin D Excess Is Significantly Associated with Risk of Atrial Fibrillation. Circulation. 124. 4 indexed citations

18.

Bunch, T. Jared, Brian G. Crandall, J. Peter Weiss, et al.. (2011). Abstract 14708: Pradaxa Can Be Safely Used As Monotherapy Or As A Bridge To Therapeutic Warfarin After Atrial Fibrillation Ablation. Circulation. 124. 1 indexed citations

19.

Christensen, Nedra, Shiquan Wang, John Day, et al.. (2010). Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies. Cardiology. 116(1). 61–69. 50 indexed citations

20.

Bunch, T. Jared, Jennifer Nelson, Brian G. Crandall, et al.. (2006). Temporary Esophageal Stenting Allows Healing of Esophageal Perforations Following Atrial Fibrillation Ablation Procedures. Journal of Cardiovascular Electrophysiology. 17(4). 435–439. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact